Results 21 to 30 of about 211,577 (291)

RBR E3‐ligases at work [PDF]

open access: yesEMBO reports, 2014
The RING-in-between-RING (RBR) E3s are a curious family of ubiquitin E3-ligases, whose mechanism of action is unusual in several ways. Their activities are auto-inhibited, causing a requirement for activation by protein-protein interactions or posttranslational modifications.
Judith J, Smit, Titia K, Sixma
openaire   +2 more sources

A Comprehensive Atlas of E3 Ubiquitin Ligase Mutations in Neurological Disorders

open access: yesFrontiers in Genetics, 2018
Protein ubiquitination is a posttranslational modification that plays an integral part in mediating diverse cellular functions. The process of protein ubiquitination requires an enzymatic cascade that consists of a ubiquitin activating enzyme (E1 ...
Arlene J. George   +4 more
doaj   +1 more source

Ubiquitin E3 ligase FIEL1 regulates fibrotic lung injury through SUMO-E3 ligase PIAS4 [PDF]

open access: yesThe Journal of Cell Biology, 2016
The E3 small ubiquitin-like modifier (SUMO) protein ligase protein inhibitor of activated STAT 4 (PIAS4) is a pivotal protein in regulating the TGFβ pathway. In this study, we discovered a new protein isoform encoded by KIAA0317, termed fibrosis-inducing E3 ligase 1 (FIEL1), which potently stimulates the TGFβ signaling pathway through the site-specific
Lear, Travis   +10 more
openaire   +2 more sources

Pto kinase binds two domains of AvrPtoB and its proximity to the effector E3 ligase determines if it evades degradation and activates plant immunity. [PDF]

open access: yesPLoS Pathogens, 2014
The tomato--Pseudomonas syringae pv. tomato (Pst)--pathosystem is one of the best understood models for plant-pathogen interactions. Certain wild relatives of tomato express two closely related members of the same kinase family, Pto and Fen, which ...
Johannes Mathieu   +2 more
doaj   +1 more source

Inhibiting E3 ligases [PDF]

open access: yesScience-Business eXchange, 2010
Two groups of researchers have identified inhibitors of E3 ubiquitin ligase, which has been considered difficult, if not impossible, to target with small molecules. The findings could lead to compounds that are more specific disrupters of tumor cell proliferation than the proteasome inhibitor Velcade bortezomib.
openaire   +1 more source

Biochemical characterization of TRIM72 E3 ligase and its interaction with the insulin receptor substrate 1

open access: yesBiochemistry and Biophysics Reports, 2020
TRIM family of E3 ubiquitin ligases have an amino-terminal conserved tripartite motif consisting of RING, B-Box, coiled-coil domain and different C-terminal domain leading it to classification into 11 subclasses.
Ishita Gupta   +3 more
doaj   +1 more source

An ORFeome of rice E3 ubiquitin ligases for global analysis of the ubiquitination interactome

open access: yesGenome Biology, 2022
Background Ubiquitination is essential for many cellular processes in eukaryotes, including 26S proteasome-dependent protein degradation, cell cycle progression, transcriptional regulation, and signal transduction.
Ruyi Wang   +26 more
doaj   +1 more source

Inhibitors of ubiquitin E3 ligase as potential new antimalarial drug leads

open access: yesBMC Pharmacology and Toxicology, 2017
Background Protein ubiquitylation is an important post-translational regulation, which has been shown to be necessary for life cycle progression and survival of Plasmodium falciparum.
Jagrati Jain   +3 more
doaj   +1 more source

Exploration of Aberrant E3 Ligases Implicated in Alzheimer’s Disease and Development of Chemical Tools to Modulate Their Function

open access: yesFrontiers in Cellular Neuroscience, 2021
The Ubiquitin Proteasome System (UPS) is responsible for the degradation of misfolded or aggregated proteins via a multistep ATP-dependent proteolytic mechanism. This process involves a cascade of ubiquitin (Ub) transfer steps from E1 to E2 to E3 ligase.
Frances M. Potjewyd, Alison D. Axtman
doaj   +1 more source

E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones

open access: yesSLAS discovery : advancing life sciences R & D, 2020
Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease.
T. Ishida, A. Ciulli
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy